Misplaced Pages

Citiolone

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is the current revision of this page, as edited by Boghog (talk | contribs) at 05:28, 30 October 2023 (consistent citation formatting). The present address (URL) is a permanent link to this version.

Revision as of 05:28, 30 October 2023 by Boghog (talk | contribs) (consistent citation formatting)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Chemical compound Pharmaceutical compound
Citiolone
Clinical data
ATC code
Identifiers
IUPAC name
  • (RS)-N-(2-Oxothiolan-3-yl)acetamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.013.449 Edit this at Wikidata
Chemical and physical data
FormulaC6H9NO2S
Molar mass159.20 g·mol
InChI
  • InChI=1S/C6H9NO2S/c1-4(8)7-5-2-3-10-6(5)9/h5H,2-3H2,1H3,(H,7,8)
  • Key:NRFJZTXWLKPZAV-UHFFFAOYSA-N
  (what is this?)  (verify)

Citiolone is a drug used in liver therapy.

It is a derivative of the amino acid cysteine. Citilone has also been studied with regards to hypothermia due to it being a hydroxyl free radical scavenger. The drug has been shown to protect hamster cells subjected to temperature conditions of 8-25 °C.

References

  1. de Barrio M, Tornero P, Prieto A, Sainza T, Zubeldia JM, Herrero T (1997). "Recurrent fixed drug eruption caused by citiolone". Journal of Investigational Allergology & Clinical Immunology. 7 (3): 193–194. PMID 9252880.
  2. Kruuv J, Glofcheski DJ (June 1993). "Further evidence for two modes of hypothermia damage". Cryobiology. 30 (3): 313–321. doi:10.1006/cryo.1993.1030. PMID 8370318.
Bile and liver therapy (A05)
Bile therapy
Liver therapy
Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

Categories: